Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01944098 · ClinicalTrials.gov registry record · Phase 3

Intraoperative Lidocaine Infusion for Postoperative Pain Management in Obese Patients

A Phase 3 study, sponsored by University of South Florida.

Completed
Registry status
Phase 3
Development phase
20
Enrollment target

NCT01944098 is a Phase 3 study that has completed, run by University of South Florida. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01944098, a Phase 3 study, has completed, sponsored by University of South Florida.

COMPLETED
Registry status
Phase 3
Development phase
20 participants
Enrollment target

Study Summary

The primary objective is to assess the feasibility and safety of administering continuous intraoperative lidocaine infusions in adult patients undergoing laparoscopic Roux en Y Gastric Bypass (RYGB). The secondary objective is to determine if lidocaine administration versus placebo (dextrose administration) (initiated at the time of anesthesia induction and continued until extubation) will reduce postoperative narcotic requirements.

Interventions

  • DRUG Placebo
  • DRUG Lidocaine

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2013-08
Est. Completion 2014-09
Phase Phase 3

Sponsor

University of South Florida

252 total trials

What the Registry Record Tells You About NCT01944098

The ClinicalTrials.gov registry entry for NCT01944098 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT01944098 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01944098 about?

NCT01944098 is a clinical study titled "Intraoperative Lidocaine Infusion for Postoperative Pain Management in Obese Patients". The primary objective is to assess the feasibility and safety of administering continuous intraoperative lidocaine infusions in adult patients undergoing laparoscopic Roux en Y Gastric Bypass (RYGB). The secondary objective is to determine if lidocaine administration versus placebo (dextrose adminis...

What is the current status of trial NCT01944098?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2013-08. Estimated completion is 2014-09.

What interventions are being tested in trial NCT01944098?

The interventions under investigation include: Placebo (DRUG), Lidocaine (DRUG).

Who is sponsoring clinical trial NCT01944098?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.